One of every three cases of infective endocarditis followed in our center is Brucella endocarditis

Year 2013, Volume: 19 Issue: 2, 103 - 107, 01.03.2013

Kaya Zekeriya Ali Yıldız Biçer Asuman Yeşilay Aydemir Koçaslan Mehmet Salih Aydın Yusuf Sezen Ramazan Asoğlu Özgür Günebakmaz Recep Demirbağ

https://doi.org/10.5455/GMJ-30-2013-136

Abstract

The purpose of this study is to determine the epidemiological, clinical and laboratory characteristics and prevalence of Brucella endocarditis followed in our hospital was. The study were included 24 infective endocarditis (EE) patients (12 female, 12 male, mean age, 41.3 years, range, 12-85 years) followed in our clinic between 2008-2012 and diagnosed with modified Duke criteria. The demographic, clinical, echocardiographic, laboratory variables, treatment and follow-up data were evaluated. EE was associated with in 20 patients (83.3%), natural valve, 4 (12.2%), mechanical prosthetic valve and 1 patient (4.2%) a permanent pacemaker. Among natural valves, mitral valve was the most frequently involvement (45% of mitral, aortic 35%, tricuspid valve 10%). Mitral valve was most commonly affected prosthetic valves (100%). The most common symptoms included fever (66.7%), chills and sweating (37.5%), fatigue (12.5%). Vegetation was the most common lesion (66.6%) in transthoracic and/or transesophageal echocardiography. In bacterial cultures, brucella were isolated the most common bacteria (33%). Staphylococcus (21%) and Streptococcus (17%) was positive in cultures and in 5 (20.8%) cases were culture negative. Nine patients (37.4%) underwent surgical treatment. 50% of the native aortic valve, aortic valve replacement 12.5%, 25% and 12.5% of the prosthetic mitral valve and native mitral valve was patients with the diagnosis of brucellosis. Clinical signs of brucella endocarditis were similar with EE. Surgery and medical treatment are the most commonly used treatment in brucella endocarditis. Young age (mean age, 38.9 years), aortic involvement (62.5%), native valve involvement (62.5%), prolonged incubation period (average 10 days) were features of Brucella endocarditis. The characteristics of EE showed similar to literature results. At our center 1/3's EE patients were seen due to Brucella bacteries. Brucella endocarditis should be considered features young age, aortic involvement, native valvuler involvement and long incubation period.

Keywords

Brucella endocarditis; infective endocarditis.

Merkezimizde takip edilen her üç enfektif endokardit olgusundan birisi Brusella endokarditidir

Abstract

Bu çalışma ile hastanemizde takip edilen enfektif endokardit (EE) olgularının epidemiyolojik, klinik, laboratuar özellikleri ile Brusella endokarditinin merkezimizdeki sıklığının ve özelliklerinin belirlenmesi amaçlanmıştır. Çalışmaya, 2008-2012 yılları arasında, kliniğimizde takip edilen ve modifiye Duke kriterlerine göre EE tanısı konulan 24 hasta (12 kadın,12 erkek; ortalama yaş; 41,3 yıl, yaş aralığı; 12-85 yıl) alındı. Hastaların demografik, klinik, ekokardiyografik, laboratuar, tedavi ve takip verileri değerlendirildi. Hastaların 20'sinde (%83,3) doğal kapak, 3'ünde (%12,5) mekanik protez kapak, 1'inde (%4,2) kalıcı kalp pili ile ilişkili EE saptandı. Doğal kapak tutulumunda en sık mitral etkilenmişti (Mitral %45; aortik kapak %35; triküspit kapak %10). Protez kapaklarda da en sık etkilenen kapak mitral kapak (%100) idi. En sık görülen semptomlar arasında ateş (% 66,7), titreme ve terleme (%37,5), halsizlik (%12,5) mevcuttu. Transtorasik ve/veya transözofageal ekokardiyografide en sık bulgu vejetasyondu (%66,6). Kültürlerde en sık Brusella (%33), stafilokok (%21) ve streptokok (%17) üredi; 5 (%20,8) olguda ise üreme olmadı. Toplamda 9 hastaya (%37,4) cerrahi tedavi uygulandı. Brusella tanısı konulanların % 50'si nativ aortik kapak, % 12,5 protez aortik kapak, %25 protez mitral kapak ve % 12,5 nativ mitral kapak idi. Brusella endokarditinin kliniği EE kliniği ile benzerdi. Brusella endokarditinde cerrahi+medikal tedavi en sık uygulanan tedaviydi. Genç yaş (ortalama yaş;38,9 yıl), aortik tutulum (%62,5), nativ kapak tutulum (%62,5), uzun süren inkübasyon periyodu (ortalama 10 gün) Brusella endokarditinin özellikleri arasında idi. EE özellikleri literatürdeki sonuçlar ile benzerlik göstermekteydi. Merkezimizdeki EE hastalarının 1/3'i gibi yüksek oranlarda Brusella endokarditi görülmekteydi. Genç yaş, aortik tutulum, nativ kapak, uzun inkübasyon periyodu gibi özellikleri taşıyan endokarditlerde Brusella endokarditi mutlaka düşünülmelidir.

Keywords

Brusella endokarditi, enfektif endokardit

References

• 1. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30(19):2369-413.
• 2. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009;169:463–73.
• 3. Robert OB, Douglas L. Mann, Douglas P. Zipes, and Peter Libby. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. In Adolf WK. Infective Endocarditis. International Edition, 9th Edition. 1540-56
• 4. Çevik M.A. Brusella Epidemiyolojisi. ANKEM Dergisi 2003;17:340-3.
• 5. Boşnak VK, Karaoğlan İ, Namıduru M, Erdem M, Baydar İ. Antibiyotik tedavisi ile düzenlenen brucella melitensis’e bağlı protez kapak endokarditi olgusu. ANKEM Derg 2011;25(2):111-3.
• 6. ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused Update on Infective Endocarditis. Circulation 2008;118:887-96.
• 7. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
• 8. Tornos P, Iung B, Permanyer-Miralda G, Baron G, Delahaye F, Gohlke-Bärwolf Ch et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart 2005;91(5):571-5.
• 9. Sucu M, Davutoğlu V, Ozer O, Aksoy M. Epidemiological, clinical and microbiological profile of infective endocarditis in a tertiary hospital in the South-East Anatolia Region. Türk Kardiyol Dern Arş 2010;38(2):107-11.